Back to search

Article

Repurposing Nintedanib for Pathological Cardiac Remodeling and Dysfunction

2020-12-22

Abstract excerpt

<h4>Background</h4> Heart Failure (HF) is the leading cause of death worldwide. Myocardial fibrosis, one of the clinical manifestations implicated in almost every form of heart disease, contributes significantly to HF development. However, there is no approved drug specifically designed to target cardiac fibrosis. Nintedanib (NTB) is an FDA approved tyrosine kinase inhibitor for idiopathic pulmonary fibrosis (IPF...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fa4798fb-fa29-5739-a5a3-67ecb3ee92d6
DOI
10.1101/2020.12.21.423817
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Repurposing Nintedanib for Pathological Cardiac Remodeling and DysfunctionDOI 10.1101/2020.12.21.423817
Select a neighboring publication to make it the new centre.